Plasma Matrix Metalloproteinase-9 Level Is Better than Serum Matrix Metalloproteinase-9 Level to Predict Gastric Cancer Evolution - Wu, Chun-Ying; Wu, Ming-Shiang; Chiang, En-Pei; Chen, Yi-Ju; Chen, Chien-Jen; Chi, Nai-Hui; Shih, Ying-Ting; Chen, Gran-Hum; Lin, Jaw-Town (Clinical cancer research, 2007)
Keywords: Adult; Aged; Aged, 80 and over; Antineoplastic agents; Area Under Curve; Biological and medical sciences; Biomarkers, Tumor - blood; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Gastroenterology. Liver. Pancreas. Abdomen; Gastrointestinal cancers: stomach; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Matrix Metalloproteinase 9 - blood; Medical sciences; Middle Aged; MMP-9; Pharmacology. Drug treatments; Plasma - chemistry; Prognosis; ROC Curve; Serum - chemistry; Stomach Neoplasms - blood; Stomach Neoplasms - mortality; Stomach Neoplasms - pathology; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Survival factors Tumor progression, Invasion, and Metastasis; Tumor markers and detection of metastasis; Tumors; Biological fluid; Enzyme; Metalloendopeptidases; Malignant tumor; Stomach cancer; Gelatinase B; Blood plasma; Peptidases; Digestive diseases; Hydrolases; Evolution; Serum; Predictive factor; Gastric disease